ANIP News and Press, ANI Pharmaceuticals Inc. From 11/03/21

ANI Pharmaceuticals (NASDAQ:ANIP) trades 5% down after hours on announcing its intention to offer and sell shares in an underwritten public offering. Underwriters granted 30-day option to purchase up to an additional 15% of shares. Offer size, terms not yet disclosed. Net proce...

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI”) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by ANI. The offering is subject to market conditio...

US Biopharma and transport stocks surge over the last trading session, Coke invests in the sports drinks sector, andNextech announce a private placement . Tesla Inc. ( NASDAQ: TSLA ) jumped 4% on Monday, extending its gains from last month. The electric car maker saw its...

Image source: The Motley Fool. ANI Pharmaceuticals, inc (NASDAQ: ANIP) Q3 2021 Earnings Call Nov 1, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript

Regional banks provided a significant bright spot on a generally lackluster session on Monday. A more than 20% gain in Silvergate Capital (NYSE:SI) led the sector higher, as investors focused on the company's cryptocurrency operations, part of a diversification that has marked the space recen...

Are These Top Biotech Stocks Worth Investing In This Month? Biotech stocks have and continue to make waves across the stock market today . For the most part, this would be due to the overwhelming focus on the industry amidst the pandemic. In fact, new data from Johns Hopkins Uni...

ANI Pharmaceuticals ( NASDAQ: ANIP ) recently announced that it recorded $52.1 million net revenues for its third quarter of 2021. However, this was roughly one million dollars less than what they reported in the same quarter of the previous fiscal year. The stock is up...

Shares of Ani Pharmaceuticals (NASDAQ: ANIP) took flight on Monday morning. The maker of generic and branded drugs delivered both a positive earnings report and some good news on the regulatory front -- the FDA has approved its generic version of Acthar Gel. Investors hoping for a b...

ANI Pharmaceuticals, Inc. (ANIP) Q3 2021 Earnings Conference Call November 1, 2021 8:30 am ET Corporate Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive Officer Steve Carey - Chief Financial Officer Conference Call Participants Elliot Wilbur - Raymo...

Gainers: ABVC BioPharma (NASDAQ:ABVC) +250%, ANI Pharmaceuticals (NASDAQ:ANIP) +51%, Artelo Biosciences (NASDAQ:ARTL) +37%, Nutriband (NTRBW) +34%, Regencell Bioscience (NASDAQ:RGC) +15%. Losers: Centessa Pharmaceuticals (NASDAQ:CNTA) -19%, Mi...